M. Horellou

发表

Improving Anticoagulation Control in Hospitalized Elderly Patients on Warfarin

J. Golmard, J. Cambus, I. Gouin-Thibault, 2010, Journal of the American Geriatrics Society.

Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations.

J. Golmard, Anne-Céline Martin, I. Gouin-Thibault, 2015, Thrombosis research.

Coagulation Characterization of Prothrombin 20209C > T Variant: About 27 New Cases

M. Fontenay, I. Gouin-Thibault, O. Kosmider, 2020, Thrombosis and Haemostasis.

[Non-VKA oral anticoagulants: an update for the clinical biologists].

J. Dogné, M. Samama, I. Gouin-Thibault, 2015, Annales de biologie clinique.

Intra-Coronary Thrombolysis with Streptokinase or Lys-Plasminogen/Urokinase in Acute Myocardial Infarction: Effects on Recanalization and Blood Fibrinolysis

C. Guérot, M. Samama, M. Horellou, 1983, Thrombosis and Haemostasis.

Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency.

R. Bertina, K. Bauer, R. Rosenberg, 1988, Blood.

Afibrinogenemia resulting from homozygous nonsense mutation in A alpha chain gene associated with multiple thrombotic episodes

P. de Mazancourt, M. Samama, H. Erdem, 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Hormone therapy and recurrence of venous thromboembolism among postmenopausal women

M. Horellou, J. Conard, P. Scarabin, 2011, Menopause.

Multiple genetic alterations in vitamin K epoxide reductase complex subunit 1 gene (VKORC1) can explain the high dose requirement during oral anticoagulation in humans

M. Loriot, L. Bodin, M. Horellou, 2008, Journal of thrombosis and haemostasis : JTH.

[Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].

A. Gompel, M. Horellou, J. Conard, 2008, Gynecologie, obstetrique & fertilite.

A noninvasive diagnostic strategy including spiral computed tomography in patients with suspected pulmonary embolism.

M. Horellou, J. Laaban, C. Lorut, 2000, American journal of respiratory and critical care medicine.

[Venous thromboembolism and pregnancy].

M. Horellou, G. Plu-bureau, J. Lepercq, 2015, La Revue de medecine interne.

Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays

S. Laporte, T. Lecompte, I. Gouin-Thibault, 2013, Thrombosis and Haemostasis.

Clinical Aspects and Laboratory Problems in Hereditary Thrombophilia

M. Samama, M. Horellou, I. Elalamy, 1999, Pathophysiology of Haemostasis and Thrombosis.

Biochemistry and clinical pharmacology of new anticoagulant agents

M. Samama, M. Horellou, I. Elalamy, 2002, Pathophysiology of Haemostasis and Thrombosis.

Evaluation of desmopressin for dental extractions in patients with hemostatic disorders.

M. Torchet, J. Goudemand, C. Gazengel, 1994, Oral surgery, oral medicine, and oral pathology.

Postoperative deep venous thrombosis in a woman with congenital afibrinogenaemia treated with fibrinogen concentrates.

C. Samama, M. Horellou, J. Haberer, 2008, European journal of anaesthesiology.

CONGENITAL FACTOR VII DEFICIENCY AND CEREBROVASCULAR STROKE

M. Samama, J. Lefrère, M. Horellou, 1985, The Lancet.

L-ASPARAGINASE, ANTITHROMBIN III, AND THROMBOSIS

M. Horellou, J. Conard, M. Samama, 1980, The Lancet.

Life-threatening intracranial bleeding associated with the presence of an antifactor VII autoantibody.

M. Kazatchkine, A. Delmer, R. Zittoun, 1989, Blood.

Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations

R. Tait, S. Schulman, A. Mumford, 2008, Thrombosis and Haemostasis.

Large Cohort Study of Central Venous Catheter Thrombosis during Intravenous Antibiotic Therapy

M. Horellou, S. Marmor, V. Zeller, 2015, Antimicrobial Agents and Chemotherapy.

Progestogen-only contraception in women at high risk of venous thromboembolism.

J. Thalabard, M. Horellou, J. Conard, 2004, Contraception.

Pregnancy‐associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone

M. Samama, M. Horellou, I. Elalamy, 2003, British journal of haematology.

Heritable Thrombophilia and Pregnancy Associated Thrombosis.

M. Samama, M. Horellou, I. Elalamy, 2002, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Management of Pregnancy in Women with Thrombophilia

M. Samama, M. Horellou, J. Conard, 1999, Pathophysiology of Haemostasis and Thrombosis.

Heparin‐induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation

P. Morange, Y. Gruel, P. Nguyên, 2021, Journal of thrombosis and haemostasis : JTH.

European Concerted Action on Anticoagulation (ECAA): multicentre international sensitivity index calibration of two types of point‐of‐care prothrombin time monitor systems

J. Jespersen, N. Egberg, L. Poller, 2002, British journal of haematology.

Control of Oral Anticoagulation in Patients with the Antiphospholipid Syndrome – Influence of the Lupus Anticoagulant on International Normalized Ratio

G. Reber, M. Horellou, C. Caron, 1998, Thrombosis and Haemostasis.

D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implications.

M. Horellou, I. Elalamy, J. Conard, 2005, Seminars in vascular medicine.

Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency

J. Griffin, A. Gruber, K. Bauer, 1993 .

Should women suffering from migraine with aura be screened for biological thrombophilia?: results from a cross-sectional French study.

H. Massiou, A. Gompel, M. Horellou, 2014, Thrombosis research.

First venous thromboembolism and hormonal contraceptives in young French women

A. Gompel, J. Hugon-Rodin, M. Horellou, 2017, Medicine.

Effects of long term administration of ticlopidine on platelet function and hemostatic variables.

M. Bousser, M. Samama, M. Horellou, 1980, Thrombosis research.

Red blood cell aggregability in patients with a history of leg vein thrombosis: influence of post‐thrombotic treatment

M. Samama, A. Chabanel, M. Horellou, 1994, British journal of haematology.

[Value of an extensive biological study in venous or arterial thromboses].

J. Piette, B. Chadefaux-Vekemans, F. Koskas, 1996, Presse medicale.

Antiplatelet Effects of the Addition of Acetylsalicylic Acid 40 Mg Daily to Ticlopidine in Human Healthy Volunteers

J. Maffrand, M. Samama, T. Lecompte, 1997 .

Title Page / Table of Contents / Preface

F. Sofi, R. Abbate, P. Morange, 2003, Pathophysiology of Haemostasis and Thrombosis.

Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: a case report.

C. Samama, A. Godier, M. Horellou, 2010, Thrombosis research.

[Anticoagulants (heparin, antivitamins K, principles and rules of use)].

T. Lecompte, M. Horellou, 1992, La Revue du praticien.

Acquired von willebrand disease: Correction of hemostatic defect by high‐dose intravenous immunoglobulins

C. Girard-Longhini, A. Delmer, R. Zittoun, 1992, American journal of hematology.

At III content and antithrombin in activity in oestrogen-progestogen and progestogen-only treated women.

M. Samama, M. Horellou, J. Conard, 1980, Thrombosis research.

Screening for inherited thrombotic disorders

M. Horellou, J. Conard, M. Samama, 1989, La Ricerca in clinica e in laboratorio.

Antithrombin III in Contraceptive Treatments with Oestroprogestagens or Progestagen -Only Pills

M. Samama, M. Horellou, J. Conard, 1979, Thrombosis and Haemostasis.

Antithrombin III In Patients Treated With Subcutaneous Or Intravenous Heparin

T. Lecompte, M. Horellou, J. Conard, 1981, Thrombosis and Haemostasis.

A new case of high‐molecular‐weight kininogen inherited deficiency

J. Lefrère, M. Horellou, J. Conard, 1986, American journal of hematology.

Monitoring Heparin Therapy Using Activated Partial Thromboplastin Time – Results of a Multicenter Trial Establishing the Therapeutic Range for SILIMAT, a Reagent with High Sensitivity to Heparin

M. Horellou, M. Samama, M. Trzeciak, 1998, Thrombosis and Haemostasis.

Severe prekallikrein deficiencies due to homozygous C529Y mutations.

P. de Mazancourt, M. Horellou, J. Conard, 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians].

M. Samama, M. Horellou, J. Conard, 2009, Journal des maladies vasculaires.

PROS1 genotype phenotype relationships in a large cohort of adults with suspicion of inherited quantitative protein S deficiency

A. Rauch, P. Suchon, M. Horellou, 2015, Thrombosis and Haemostasis.

Biological and clinical heterogeneity of lupus and lupus-like anticoagulant in fifty-seven patients.

M. Samama, M. Horellou, M. Boffa, 1988, Journal of medicine.

Risk assessment models for thromboprophylaxis of medical patients.

M. Samama, M. Horellou, J. Conard, 2012, Thrombosis research.

PT, aPTT, TT and the hemostatic safety threshold of dabigatran and rivaroxaban.

I. Gouin-Thibault, M. Horellou, É. Mazoyer, 2016, Annales de biologie clinique.

The Modified APC Resistance Test in the Presence of Factor V Deficient Plasma Can Be Used in Patients without Oral Anticoagulant

M. Trossaërt, M. Horellou, I. Elalamy, 1996, Thrombosis and Haemostasis.

Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency

J. Hugon-Rodin, M. Horellou, V. Picard, 2017, Thrombosis and Haemostasis.

Impact of a pneumatic tube system transport on hemostasis parameters measurement: the experiment of Cochin universitary hospital (AP-HP, Paris, France).

M. Fontenay, M. Horellou, É. Mazoyer, 2017, Annales de biologie clinique.

Combined Hormonal Contraceptives and First Venous Thrombosis in Young French Women: Impact of Thrombotic Family History

A. Gompel, J. Hugon-Rodin, M. Horellou, 2017, Journal of the Endocrine Society.

Inherited thrombophilia and gestational venous thromboembolism.

M. Samama, M. Horellou, J. Conard, 2003, Seminars in thrombosis and hemostasis.

Familial and constitutional bleeding disorder due to platelet cyclo‐oxygenase deficiency

B. Vargaftig, M. Chignard, F. Fouque, 1983, American journal of hematology.

Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.

F. Chédru, M. Bousser, M. Samama, 1996, Stroke.

Acquired hemophilia due to factor VIII inhibitors in 34 patients.

J. Pouchot, O. Chosidow, R. Zittoun, 1998, The American journal of medicine.

A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene.

C. Mannhalter, M. Horellou, A. Zivelin, 1998, Blood.

Risk assessment models for thromboprophylaxis of medical patients.

M. Samama, M. Horellou, J. Conard, 2012, Thrombosis research.

Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: a case report.

C. Samama, A. Godier, M. Horellou, 2010, Thrombosis research.

Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency.

J. Griffin, A. Gruber, K. Bauer, 1993, Blood.